SavranTech announced today that its abstract has been selected for oral presentation at the Society for Reproductive Investigation (SRI) 2026 Annual Scientific Meeting, one of the leading international conferences in reproductive and maternal health research.

The selected presentation will highlight SavranTech’s work on early, non-invasive detection of preeclampsia using its proprietary cell-based diagnostic platform. Selection for an oral presentation reflects the scientific merit and relevance of the work, as only a limited number of abstracts are chosen for this format.

“This recognition by SRI underscores the growing interest in earlier, more actionable approaches to preeclampsia detection,” said Dr. Cagri Savran, CEO of SavranTech. “We view this as an important step in sharing our science with the maternal–fetal medicine and research community as we advance toward clinical validation and pre-launch activities.” SavranTech’s presentation at SRI 2026 represents an important milestone in the company’s scientific and clinical development roadmap.

About the SRI Annual Scientific Meeting

The Society for Reproductive Investigation (SRI) Annual Scientific Meeting is a premier international conference bringing together leading researchers and clinicians in reproductive biology, maternal–fetal medicine, and women’s health. The meeting highlights high-impact translational and clinical research shaping the future of reproductive and pregnancy care.